Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Taipei Veterans General Hospital, Taipei, Taiwan
West China Hospital of Sichuan University, Chengdu, China
Ain Shams University hospitals, Cairo, Egypt
Amer A Attieh, Mansourah, DK, Egypt
2nd Department of Anesthesiology, Attikon Hospital, 1 Rimini str., Athens, Greece
Instituto da Criança do Hospital das Clinicas da FMUSP, São Paulo, Brazil
Clinical trial Ethnics Committee of Peking Union Medical College Hospital, Beijing, Beijing, China
Hotel Dieu de France Hospital, Beirut, Lebanon
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.